Cardea Bio
ExitedCardea Bio is the world’s only mass producer of biocompatible semiconductors, the BPU™ (Biosignal Processing Unit).
Cardea Bio is tracked in the Tech.eu funding database. Based in San Diego, United States; active in Semiconductors. Acquired by Paragraf in 2023. Data as of 28 Oct 2026.
San Diego, United Stateswww.cardeabio.com ↗
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Related news
Similar companies
same sector or country- Arm€4.7BUK · Semiconductors
- NXP Semiconductors€1.0BNetherlands · Semiconductors
- Nearfield Instruments€523MNetherlands · Semiconductors
- Kandou€470MSwitzerland · Semiconductors
- Olix€456MUK · Semiconductors
- Remote€440MUnited States · HRtech
Global coverage: FundingData